Abstract
摘要
相似文献
1
[Hypo-uricemia].[低尿酸血症]
Rev Prat. 1989 Oct 11;39(23):2079-82.
2
[Treatment of hyperuricemias in hematology using urate oxidase and allopurinol].[使用尿酸氧化酶和别嘌呤醇治疗血液学中的高尿酸血症]
Ann Med Interne (Paris). 1976 Jun-Jul;127(6-7):479-82.
3
[Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology].[信件：尿酸氧化酶和别嘌醇作为血液学中降尿酸药物的应用]
Nouv Presse Med. 1976 Jan 10;5(2):91.
4
[Uric acid and its metabolism].[尿酸及其代谢]
Presse Med (1893). 1968 Dec 14;76(49):2317-8.
5
[Data on changes in blood and urinary uric acid induced by a urate oxidase].[尿酸氧化酶引起的血液和尿液尿酸变化的数据]
Rev Rhum Mal Osteoartic. 1972 Feb;39(2):138-40.
6
[Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].[促尿酸排泄药：是否应用于无症状性高尿酸血症？]
Tidsskr Nor Laegeforen. 1976 Jan 10;96(1):45-6.
7
Hypouricaemic effect of polyethyleneglycol modified urate oxidase.
Lancet. 1981 Aug 8;2(8241):281-3. doi: 10.1016/s0140-6736(81)90528-6.
8
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.降尿酸药物治疗痛风的疗效及耐受性：别嘌醇治疗失败后苯溴马隆与丙磺舒的随机对照试验
Ann Rheum Dis. 2009 Jan;68(1):51-6. doi: 10.1136/ard.2007.083071. Epub 2008 Feb 4.
9
Letter: Treatment of malignant haemopathies and urate oxidase.信件：恶性血液病的治疗与尿酸氧化酶
Lancet. 1975 Jan 25;1(7900):229. doi: 10.1016/s0140-6736(75)91410-5.
10
[Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].[在痛风及其他高尿酸血症状态下使用尿酸氧化酶进行酶治疗期间嘌呤排泄的方式]
Presse Med (1893). 1968 Dec 14;76(49):2325-7.
Zotero 插件